• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Opinions
    • Top 30
    • Research
    • Supply Chain
    • Device Sectors
    • Directory
    • Events
    • Resources
    • Microsites
    • More
  • Magazine
  • News
  • Opinions
  • Top 30
  • Research
  • Supply Chain
  • Device Sectors
  • Directory
  • Events
  • Resources
  • Microsites
  • Current / Back Issues
    Features
    Editorial
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Reprints
    Subscribe Now
    Advertise Now
    Top Features
    Cybersecurity Challenges Leave Medical Device Makers Insecure

    OEMs Are Demanding Designs that Challenge Suppliers

    Diabetes Technology Manufacturers Seemingly on a Sugar Rush

    Post-Pandemic Partnerships: A Full-Service Outsourcing Discussion

    Discovering the Value of Surface Treatments and Coatings for Medtech
    OEM News
    Supplier News
    Service / Press Releases
    Online Exclusives
    Press Releases
    People in the News
    Product & Service Releases
    Supplier News
    Medtech Makers
    Technical Features
    International News
    Videos
    Product & Service Releases
    Live From Shows
    Regulatory
    Financial/Business
    Top News
    Pediatric Medical Device Competition Reveals Five Finalists

    Medical Device Packaging Market to Reach $34B by 2027

    Penumbra Secures CE Mark for its Advanced Mechanical Thrombectomy Tech

    Digital Twin Tech to Significantly Impact India's Cardiology Devices Sector

    Anumana's ECG Pulmonary Hypertension AI Algorithm Gains Breakthrough Status
    From the Editor
    Blogs
    Guest Opinions
    Top Opinions
    Cybersecurity Challenges Leave Medical Device Makers Insecure

    OEMs Are Demanding Designs that Challenge Suppliers

    Diabetes Technology Manufacturers Seemingly on a Sugar Rush

    Post-Pandemic Partnerships: A Full-Service Outsourcing Discussion

    Discovering the Value of Surface Treatments and Coatings for Medtech
    Top 30 Medical Device Companies
    Market Data
    White Papers
    Top Research
    Injecting Neurostimulators into Blood Vessels (We Swear, It’s Not Sci-Fi)

    Understanding the Costs of Care in the OR

    Sick of Being Sick: Pandemic Fatigue Flares at AAOS

    Managing Critical Healthcare Supply Chains in Turbulent Times

    To Drive Value, Human Capital Leaders Turn to Outsourced Solutions
    3D/Additive Manufacturing
    Contract Manufacturing
    Electronics
    Machining & Laser Processing
    Materials
    Molding
    Packaging & Sterilization
    R&D & Design
    Software & IT
    Testing
    Tubing & Extrusion
    Cardiovascular
    Diagnostics
    Digital Health
    Neurological
    Patient Monitoring
    Surgical
    Orthopedics
    All Companies
    Categories
    Company Capabilities
    Add New Company
    Outsourcing Directory
    BMP Medical

    Xact Wire EDM Corp.

    Fusion Biotec Inc.

    Arthur G. Russell Co. Inc., The

    Concise Engineering
    MPO Summit
    Industry Events
    Webinars
    Live From Show Event
    Industry Associations
    Videos
    Career Central
    eBook
    Slideshows
    Top Resources
    3D Printing in Dental Prosthodontics, Orthodontics, and Surgery

    What New Tech Can Improve Your Medical Manufacturing Plant?

    Why Medical Device Firms Must Navigate the Muddy Waters of ESG Requirements

    Medical Device Servicing vs. Remanufacturing

    Digital Marketplaces for Medical Equipment Come of Age
    Companies
    News Releases
    Product Releases
    Press Releases
    Product Spec Sheets
    Service Releases
    Case Studies
    White Papers
    Brochures
    Videos
    Outsourcing Directory
    BMP Medical

    Xact Wire EDM Corp.

    Fusion Biotec Inc.

    Arthur G. Russell Co. Inc., The

    Concise Engineering
    • Magazine
      • Current/Back Issues
      • Features
      • Editorial
      • Columns
      • Digital Editions
      • Subscribe Now
      • Advertise Now
    • News
    • Directory
      • All Companies
      • ALL CATEGORIES
      • Industry Associations
      • Company Capabilities
      • Add Your Company
    • Supply Chain
      • 3D/Additive Manufacturing
      • Contract Manufacturing
      • Electronics
      • Machining & Laser Processing
      • Materials
      • Molding
      • Packaging & Sterilization
      • R&D & Design
      • Software & IT
      • Testing
      • Tubing & Extrusion
    • Device Sectors
      • Cardiovascular
      • Diagnostics
      • Digital Health
      • Neurological
      • Patient Monitoring
      • Surgical
      • Orthopedics
    • Top 30 Company Report
    • Expert Insights
    • Slideshows
    • Videos
    • eBook
    • Resources
    • Podcasts
    • Infographics
    • Whitepapers
    • Research
      • White Papers
      • Case Studies
      • Product Spec Sheets
      • Market Data
    • MPO Summit
    • Events
      • Industry Events
      • Live From Show Events
      • Webinars
    • Microsite
      • Companies
      • Product Releases
      • Product Spec Sheets
      • Services
      • White Papers / Tech Papers
      • Press Releases
      • Videos
      • Literature / Brochures
      • Case Studies
    • About Us
      • About Us
      • Contact Us
      • Advertise with Us
      • eNewsletter Archive
      • Privacy Policy
      • Terms of Use
    Breaking News

    Abbott Introduces World's First Glucose Biosensor Designed for Athletes

    The firm is collaborating with Supersapiens in launch of the Libre Sense Glucose Sport Biosensor in Europe.

    Abbott Introduces World
    As part of an observational trial, two cycling teams leading into the world's largest annual sporting event, the Tour de France, trained with Abbott's Libre Sense biosensor to track the correlation between glucose levels and their athletic performance.
    Related CONTENT
    • Abbott Begins Study for New Esprit BTK Fully Resorbable Stent
    • Feds to Buy $760M of Abbott's $5, 15-Minute COVID-19 Test
    • Abbott Begins Study Evaluating New Device to Treat Recurrent AFib
    • FDA OKs Abbott’s iOS-Compatible Therapy Management App
    • FDA Approves Abbott's Next-Gen Gallant ICDs, CRT-Ds
    PR Newswire09.18.20
    Abbott is introducing the world's first glucose sport biosensor,1 Libre Sense Glucose Sport Biosensor, which is designed for athletes to continuously measure glucose to better understand the correlation between their glucose levels and their athletic performance. The Libre Sense biosensor is based on Abbott's world-leading2 FreeStyle Libre continuous glucose monitoring technology, which was originally developed for people living with diabetes. Based on that technology, this is the first personal-use product that allows for use beyond diabetes.

    Abbott's Libre Sense Glucose Sport Biosensor, with CE Mark (Conformité Européenne), is a consumer over-the-counter product that provides glucose monitoring via a mobile app3 to athletes (ages 16 years and older) performing sports such as cycling, running, and swimming, to understand the efficacy of their nutrition choices on training and competition. Tracking and understanding glucose levels enable athletes to fuel appropriately through nutrition to help avoid fatigue from low glucose and to know when to replenish during training and competition to maintain peak performance.

    "FreeStyle Libre changed the way millions of people manage their diabetes to get and stay healthier, and now with Libre Sense we're bringing that same proven technology to empower athletes to help them reach their athletic performance goals," said Jared Watkin, senior vice president, Diabetes Care, Abbott. "This is just the beginning—our breakthrough sensing technology has the potential to go beyond glucose and provide a lens into what's happening in the human body that could provide meaningful insights into other conditions, treatments, and ultimately improve health."

    Proper nutrition at the right intervals allows athletes to maintain a stable glucose level during endurance activities, which is important for managing overall energy and avoiding muscle fatigue. A study published in the American College of Sports Medicine showed that an athlete who understands the effects of their nutritional intake will have a better chance at improving their performance during exercise.4 In addition, research has shown that understanding real-time glucose levels can guide nutritional intake to help improve muscle recovery and athletic performance.5

    To obtain glucose readings from Abbott's Libre Sense Glucose Sport Biosensor, athletes will wear the small round biosensor (approximately the size of a two Euro coin) on the back of their upper arm. The biosensor will provide real-time glucose values and can be worn for up to 14 days. The user will automatically receive streaming glucose data, via Bluetooth wireless technology, every minute designed to work with compatible mobile apps and wrist readers.

    Working together with sports technology companies for distribution, Abbott's Libre Sense Glucose Sport Biosensor is designed to be compatible with these companies' mobile apps and other accessory devices. Abbott's first non-exclusive collaboration is with Supersapiens, an Atlanta-based sports technology company that is focused on improving athletic performance. Their mission is to provide athletes with actionable and personalized insights on real-time biometric data, starting with glucose.

    "With Abbott's Libre Sense, for the first time, an athlete will have access to glucose data to help give them insight into their body's fuel level at all times, fundamentally changing the way athletes think about energy management," said Phil Southerland, founder of Supersapiens and former professional cyclist. "By combining Abbott's proven track record in glucose sensing technology along with Supersapiens' app and personalized analytics, athletes will be primed to sustain peak performance."

    Supersapiens has partnered with some of the top teams at the Tour de France, the largest annual sporting event in the world, who are utilizing the energy management system and have worn the Libre Sense biosensor in training as part of an observational trial. Through this experience, the athletes were able to track their glucose data to help inform them of fueling strategies to prepare them for the race.

    Abbott's Libre Sense Glucose Sport Biosensor will be available in the coming weeks directly through the Supersapiens website. The product will initially be made available across eight European countries: Austria, France, Germany, Ireland, Italy, Luxembourg, Switzerland and the United Kingdom.

    For more information about Abbott's Libre Sense Glucose Sport Biosensor System, visit LibreSense.com.

    References
    1 The biosensor is the world's first continuous glucose biosensor specifically designed for athletes; data on file, Abbott.
    2 Data on file, Abbott Diabetes Care. Data based on the number of users worldwide for the FreeStyle Libre system compared to the number of users for other leading personal use, sensor-based glucose monitoring systems.
    3 Biosensor is designed to work with compatible partner mobile apps.
    4 Moore, D. 2015. Nutrition to Support Recovery from Endurance Exercise: Optimal Carbohydrate and Protein Replacement. American College of Sports Medicine. 14(4), pp. 294-300.
    5 Olsson, J. 2016. Swedish School of Sport and Health Sciences, GIH, Department of Sport and Health Sciences. Swedish Elite Swimmers Blood Glucose Levels During Recovery: A Descriptive Study Using Continuous Glucose Monitoring Systems.
    Related Searches
    • Patient Monitoring
    Related Knowledge Center
    • Patient Monitoring
    Suggested For You
    Abbott Begins Study for New Esprit BTK Fully Resorbable Stent Abbott Begins Study for New Esprit BTK Fully Resorbable Stent
    Feds to Buy $760M of Abbott Feds to Buy $760M of Abbott's $5, 15-Minute COVID-19 Test
    Abbott Begins Study Evaluating New Device to Treat Recurrent AFib Abbott Begins Study Evaluating New Device to Treat Recurrent AFib
    FDA OKs Abbott’s iOS-Compatible Therapy Management App FDA OKs Abbott’s iOS-Compatible Therapy Management App
    FDA Approves Abbott FDA Approves Abbott's Next-Gen Gallant ICDs, CRT-Ds
    Abbott Abbott's Freestyle Libre 2 iCGM Cleared in U.S. For Adults and Children with Diabetes
    Philips Philips' Wearable Biosensor Gains FDA OK, CE Mark to Monitor COVID-19 Patients
    Abbott Buries N.Y. Study with Positive ID NOW COVID-19 Test Results Abbott Buries N.Y. Study with Positive ID NOW COVID-19 Test Results
    FDA Warns About Possible Accuracy Concerns With Abbott Coronavirus Test FDA Warns About Possible Accuracy Concerns With Abbott Coronavirus Test
    Abbott Earns EUA for COVID-19 Molecular Test on Alinity m System Abbott Earns EUA for COVID-19 Molecular Test on Alinity m System
    FDA Grants EUA to VitalConnect FDA Grants EUA to VitalConnect's Cardiac Monitoring in COVID-19 Patients
    Philips Philips' Smart Biosensor Remotely Monitors Hospitalized COVID-19 Patients
    Medtech Execs Named to White House Economic Task Force Medtech Execs Named to White House Economic Task Force
    Abbott Launches COVID-19 Antibody Blood Test Abbott Launches COVID-19 Antibody Blood Test
    Abbott Abbott's TriClip Transcatheter Tricuspid Valve Repair Gains CE Mark

    Related Content

    • Cardiovascular
      Abbott Begins Study for New Esprit BTK Fully Resorbable Stent

      Abbott Begins Study for New Esprit BTK Fully Resorbable Stent

      Will evaluate bioresorbable device to treat blocked arteries below the knees.
      PR Newswire 09.03.20

    • Diagnostics
      Feds to Buy $760M of Abbott

      Feds to Buy $760M of Abbott's $5, 15-Minute COVID-19 Test

      150 million tests, which require no lab equipment, will be strategically distributed to where they’re needed most.
      HHS.gov U.S. Department of Health & Human Services 08.28.20

    • Cardiovascular
      Abbott Begins Study Evaluating New Device to Treat Recurrent AFib

      Abbott Begins Study Evaluating New Device to Treat Recurrent AFib

      Study will evaluate the performance of the investigational TactiFlex Ablation Catheter, Sensor Enabled.
      PR Newswire 08.07.20


    • Digital Health
      FDA OKs Abbott’s iOS-Compatible Therapy Management App

      FDA OKs Abbott’s iOS-Compatible Therapy Management App

      App allows people living with chronic pain and movement disorders to personalize therapy via their mobile device.
      PR Newswire 07.23.20

    • Cardiovascular
      FDA Approves Abbott

      FDA Approves Abbott's Next-Gen Gallant ICDs, CRT-Ds

      The devices feature Bluetooth connectivity and continuous remote monitoring.
      PR Newswire 07.06.20


      Trending
      • Quality Management Evolution: What to Expect in 2022
      • Dexcom Reportedly In Talks To Acquire Insulet | Medical Product Outsourcing
      • Shrinking Medical Devices Create Sizable Challenges For Micromolders | Medical Product Outsourcing
      • 5 Ways Plastics Revolutionized The Healthcare Industry | Medical Product Outsourcing
      • Prometheus Group Sued Over Reused Catheters And Rectal Sensors | Medical Product Outsourcing
      Breaking News
      • Pediatric Medical Device Competition Reveals Five Finalists
      • Medical Device Packaging Market to Reach $34B by 2027
      • Penumbra Secures CE Mark for its Advanced Mechanical Thrombectomy Tech
      • Digital Twin Tech to Significantly Impact India's Cardiology Devices Sector
      • Anumana's ECG Pulmonary Hypertension AI Algorithm Gains Breakthrough Status
      View Breaking News >
      CURRENT ISSUE

      May 2022

      • Cybersecurity Challenges Leave Medical Device Makers Insecure
      • Contract Design for Medtech
      • Diabetes Medical Device Technology Update
      • Medtech Full-Service Outsourcing Q&A 2022

      Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
      You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

      • About Us
      • Privacy Policy
      • Terms And Conditions
      • Contact Us

      follow us

      Subscribe
      Nutraceuticals World

      Latest Breaking News From Nutraceuticals World

      Thorne Relaunches Gut Health Test with Microbiome Wipe
      Alkemist Labs Announces Alkemist Assured Seal and Next Generation Transparency Reports
      GC Rieber Foundations Expand Philanthropic Efforts
      Coatings World

      Latest Breaking News From Coatings World

      PPG Hosts The Future of Coatings' Technology Innovation Day in Amsterdam
      Azelis Expands Presence in India with Acquisition of Chemo India and Unipharm Laboratories
      Teknos Publishes Sustainability Report
      Medical Product Outsourcing

      Latest Breaking News From Medical Product Outsourcing

      Pediatric Medical Device Competition Reveals Five Finalists
      Medical Device Packaging Market to Reach $34B by 2027
      Penumbra Secures CE Mark for its Advanced Mechanical Thrombectomy Tech
      Contract Pharma

      Latest Breaking News From Contract Pharma

      Mirum Pharmaceuticals Acquires San Diego-based Satiogen
      Catalyst Biosciences Sells Complement Portfolio to Vertex Pharmaceuticals
      Insmed Appoints Drayton Wise as Chief Commercial Officer
      Beauty Packaging

      Latest Breaking News From Beauty Packaging

      La Roche-Posay Launches Matte Moisturizer for Oily Skin
      3 Amorepacific Employees Stole $2.3 Million
      L'Oreal CEO Nicolas Hieronimus On Sustainability Initiatives
      Happi

      Latest Breaking News From Happi

      Thayers Natural Remedies Celebrates 175 Years with Social Campaign
      Former Model Shirley Powell’s Indie Beauty Brand LaJeanell Comprises Gender Inclusive Skincare and Makeup
      L’Oréal's New UVMune 400 Sun Filtering Technology Protects Skin From Ultra-Long UVA Rays
      Ink World

      Latest Breaking News From Ink World

      Flint Group Flexible Packaging Europe Implements Further Price Increase
      Nazdar Launches 205 Series Inks for Roland TrueVIS SG2 and VG2 Series Printers
      Quad Adds Landa S10P Nanographic Printing Press
      Label & Narrow Web

      Latest Breaking News From Label & Narrow Web

      AWA to host 22nd Global Release Liner Industry Conference & Exhibition
      Domino assists Grace Label with supply chain disruptions
      Rotocon wins AI Business Excellence Award
      Nonwovens Industry

      Latest Breaking News From Nonwovens Industry

      Rael Raises $35M in Series B Funding
      Schobertechnologies Offers Rotary Web-fed Converting Solutions
      Thorne Relaunches Gut Health Test with Microbiome Wipe
      Orthopedic Design & Technology

      Latest Breaking News From Orthopedic Design & Technology

      Study Confirms Knee Shapes are Highly Individualized
      Stryker Launches EasyFuse Dynamic Compression for Foot & Ankle
      Extremity Medical Rolls Out OMNI Stable Ankle Fracture System
      Printed Electronics Now

      Latest Breaking News From Printed Electronics Now

      InnovationLab Acquires Flexible Printed Battery Technology from Evonik
      Canatu Receives IATF 16949:2016 Certification
      Applied Materials Announces 2Q 2022 Results

      Copyright © 2022 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

      AD BLOCKER DETECTED

      Our website is made possible by displaying online advertisements to our visitors.
      Please consider supporting us by disabling your ad blocker.


      FREE SUBSCRIPTION Already a subscriber? Login